Details from two large trials of Novo Nordisk's GLP-1 drug semaglutide showed it provided no cognitive benefit for people ...

GLP-1 drugs, which include Ozempic and Wegovy, have become one of the most closely watched experimental approaches for slowing Alzheimer’s — a disease with few treatment options.

High levels of calcium are toxic to cells and contribute to loss of neurons in Alzheimer's disease. A new study published in ...

Officials say the pact, facilitated by the Indianapolis-based IU Launch Accelerator for Biosciences, is the largest single ...

People with impaired kidney function have higher levels of Alzheimer's biomarkers in their blood, but not an increased risk ...

Scientists have failed to show that weight-loss wonder drug semaglutide slows the progress of Alzheimer's disease (AD), as ...

Scientists from Yale University have revealed how the brain protects itself from the toxic effects of calcium, which may hold ...

Long-term LEQEMBI treatment suggests potential to delay disease progression from Mild Cognitive Impairment (MCI) to moderate ...

As Alzheimer’s Awareness Month comes to an end, Florida State University researchers are continuing efforts to better ...

Researchers have conducted the first study evaluating the impact of obesity on Alzheimer's disease blood biomarkers (BBMs).

For individuals diagnosed with Alzheimer’s disease or acting as the caretaker for someone with Alzheimer’s, support and ...

For years, Los Altos resident Kim Wilford watched Alzheimer’s Disease rob her beloved mother-in-law of her memories, spirit ...